Kennedy Capital Management, Inc. Marker Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.37 - $1.0 $218,343 - $590,118	-590,118 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.95 - $1.72 $20,379 - $36,897	-21,452 Reduced 3.51%	590,118 $561,000
Q3 2021 Nov 15, 2021	BUY	$1.68 - $2.88 $17,183 - $29,456	10,228 Added 1.7%	611,570 $1.03 Million
Q2 2021 Aug 16, 2021	SELL	$1.88 - $3.56 $2.27 Million - $4.3 Million	-1,208,178 Reduced 66.77%	601,342 $1.68 Million
Q1 2021 May 14, 2021	BUY	$1.47 - $3.29 $2.66 Million - $5.95 Million	1,809,520 New	1,809,520 $4.05 Million

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $228M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.